2nd PRESTIGIO Registry meetING on HIV multidrug resistance

Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population.

Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population.

Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population.

Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population.

Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population. Informazioni Utili | Today, most people living with HIV (PLWH) with access to ART successfully achieve virological suppression,  although drug resistance is still an unsolved problem that may dramatically reduce therapeutic options for this population.

Informazioni Utili | 2nd PRESTIGIO Registry meetING on HIV...

SEDE CONGRESSUALE
Hilton Milan Hotel
Via Luigi Galvani, 12
20124 Milano

PROVIDER E SEGRETERIA ORGANIZZATIVA
Effetti srl 
Via G.B. Giorgini, 16, 20151 Milano
Tel. 02 3343281 – Fax 02 33496370
Ref. Marina Lunghi  e-mail: marina.lunghi@effetti.it
www.effetti.it - www.makevent.it